Cingulate Inc.

Nasdaq:CINGNasdaq:CINGW

Pharmaceutical Preparations·KANSAS CITY, KS

CEO

Schaffer Shane J.

CFO

Callahan Jennifer L.

Financials

16 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/19/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/27/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

13 shown

Filed	Period
11/13/25	Q4 FY2025	→
8/19/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
3/26/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
8/13/24	Q3 FY2024	→
↓

News (8-K)

67 shown

Filed	Type	Description
2/17/26	Exec Change	Unregistered Sales of Equity Securities	→
2/6/26	Other	Unregistered Sales of Equity Securities	→
1/28/26	Agreement	Entry into a Material Definitive Agreement	→
1/15/26	Other	Other Events	→
1/2/26	Other	Unregistered Sales of Equity Securities	→
12/15/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/12/26	S-3	S-3	→
1/12/26	424B5	424B5	→
7/30/25	424B3	424B3	→
7/25/25	S-8	S-8	→
7/25/25	S-1/A	S-1/A	→
7/22/25	S-1	S-1	→
↓

Filing History(438 filings)

TypeDateAccessionPeriodSize

DEF 14A

Mar 2, 2026

0001493152-26-008441DEF 14A

Mar 2, 2026

5.0 MB

PRE 14A

Feb 18, 2026

0001493152-26-007331PRE 14A

Feb 18, 2026

5.0 MB

8-K

Feb 17, 2026

0001493152-26-0069428-K

Feb 13, 2026

279.3 KB

Feb 10, 2026

0001493152-26-0060274

Feb 6, 2026

8.3 KB

Feb 10, 2026

0001493152-26-0060264

Feb 6, 2026

7.0 KB

Feb 10, 2026

0001493152-26-0060254

Feb 6, 2026

8.3 KB

Feb 10, 2026

0001493152-26-0060244

Feb 6, 2026

7.0 KB

SCHEDULE 13D

Feb 9, 2026

0001140361-26-004386

—

442.3 KB

8-K

Feb 6, 2026

0001493152-26-0055618-K

Feb 6, 2026

245.3 KB

8-K

Jan 28, 2026

0001493152-26-0040308-K

Jan 27, 2026

891.2 KB

8-K

Jan 15, 2026

0001493152-26-0024178-K

Jan 12, 2026

275.8 KB

S-3

Jan 12, 2026

0001493152-26-001891S-3

—

1.8 MB

424B5

Jan 12, 2026

0001493152-26-001871424B5

—

16.7 KB

Jan 5, 2026

0001493152-26-0004554

Dec 31, 2025

5.2 KB

8-K

Jan 2, 2026

0001493152-26-0001428-K

Dec 23, 2025

243.4 KB

8-K

Dec 15, 2025

0001493152-25-0276678-K

Dec 15, 2025

9.7 MB

10-Q

Nov 13, 2025

0001493152-25-02239510-Q

Sep 30, 2025

6.3 MB

8-K

Nov 13, 2025

0001493152-25-0221328-K

Nov 13, 2025

303.5 KB

Nov 10, 2025

0001493152-25-021581

Sep 30, 2025

5.2 KB

Nov 10, 2025

0001493152-25-021580

Nov 3, 2025

5.2 KB

Nov 10, 2025

0001493152-25-021579

Nov 3, 2025

12.6 KB

8-K

Nov 10, 2025

0001493152-25-0214108-K

Nov 7, 2025

49.8 MB

8-K

Oct 14, 2025

0001493152-25-0179318-K

Oct 14, 2025

282.6 KB

8-K

Sep 25, 2025

0001493152-25-0149638-K

Sep 25, 2025

248.4 KB

8-K

Sep 5, 2025

0001493152-25-0127538-K

Aug 29, 2025

244.7 KB

25 filings shown

Filed	Form	Description
2/9/26	SCHEDULE 13D	SCHEDULE 13D	→
7/29/25	EFFECT	EFFECT	→
10/7/24	EFFECT	EFFECT	→
8/27/24	EFFECT	EFFECT	→
7/24/24	EFFECT	EFFECT	→
5/23/24	EFFECT	EFFECT	→
↓

Cingulate Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(438 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/2/26	DEF 14A	DEF 14A	→
2/18/26	PRE 14A	PRE 14A	→
8/15/25	DEF 14A	DEF 14A	→
8/5/25	PRE 14A	PRE 14A	→
4/28/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
4/25/25	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
2/10/26	4	4	→
2/10/26	4	4	→
2/10/26	4	4	→
2/10/26	4	4	→
1/5/26	4	4	→
11/10/25	4	4	→
↓